This Showcase shows how disease registry data helps researchers uncover critical insights into major health challenges, including COVID-19 outcomes in rheumatic disease patients, prostate and bladder cancer trends, kidney disease prognosis, testicular metastases, and adaptive-servoventilation therapy for sleep apnea. By analyzing large-scale patient data, these studies drive advancements in diagnosis, treatment, and health equity, shaping the future of evidence-based medicine.
Featured Story: Long-term outcomes in IgA nephropathy: Results from the UK National Registry of Rare Kidney Diseases (RaDaR)